Gemcitabine/Cyclophosphamide/5-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients: A Southern Italy Cooperative Oncology Group Phase I/II Study
- 30 June 2001
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 28, 50-56
- https://doi.org/10.1016/s0093-7754(01)80009-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Leucovorin, 5-fluorouracil, and gemcitabine: A phase I studyInvestigational New Drugs, 1999
- A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.Journal of Clinical Oncology, 1998
- Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.Journal of Clinical Oncology, 1997
- Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel - a phase II studyCancer Chemotherapy and Pharmacology, 1996
- Advanced breast cancer: a phase II trial with gemcitabine.Journal of Clinical Oncology, 1995
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991